Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| B cell | 22 studies | 23% ± 5% | |
| oligodendrocyte | 16 studies | 69% ± 19% | |
| naive B cell | 13 studies | 20% ± 4% | |
| oligodendrocyte precursor cell | 10 studies | 34% ± 14% | |
| fibroblast | 10 studies | 22% ± 6% | |
| memory B cell | 8 studies | 20% ± 3% | |
| endothelial cell | 8 studies | 25% ± 10% | |
| GABAergic neuron | 7 studies | 38% ± 20% | |
| astrocyte | 6 studies | 28% ± 11% | |
| interneuron | 6 studies | 32% ± 15% | |
| classical monocyte | 5 studies | 24% ± 10% | |
| neuron | 5 studies | 27% ± 19% | |
| glutamatergic neuron | 5 studies | 46% ± 22% | |
| precursor B cell | 5 studies | 28% ± 8% | |
| immature B cell | 4 studies | 26% ± 5% | |
| monocyte | 4 studies | 21% ± 6% | |
| renal alpha-intercalated cell | 4 studies | 36% ± 10% | |
| GABAergic interneuron | 3 studies | 20% ± 5% | |
| microglial cell | 3 studies | 27% ± 7% | |
| myeloid cell | 3 studies | 19% ± 2% | |
| amacrine cell | 3 studies | 19% ± 4% | |
| germinal center B cell | 3 studies | 30% ± 4% | |
| endothelial cell of lymphatic vessel | 3 studies | 23% ± 5% | |
| macrophage | 3 studies | 31% ± 9% | |
| adipocyte | 3 studies | 23% ± 6% | |
| plasmacytoid dendritic cell | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 4714.33 | 2637 / 2642 | 100% | 26.89 | 705 / 705 |
| thymus | 100% | 5057.47 | 653 / 653 | 99% | 34.65 | 601 / 605 |
| esophagus | 99% | 1740.22 | 1433 / 1445 | 100% | 9.61 | 183 / 183 |
| intestine | 100% | 2317.70 | 966 / 966 | 99% | 10.79 | 522 / 527 |
| stomach | 100% | 1511.20 | 358 / 359 | 99% | 12.40 | 284 / 286 |
| breast | 100% | 1898.39 | 459 / 459 | 99% | 14.44 | 1107 / 1118 |
| ovary | 100% | 1937.43 | 180 / 180 | 99% | 11.95 | 425 / 430 |
| lung | 100% | 2334.48 | 577 / 578 | 99% | 10.07 | 1140 / 1155 |
| skin | 100% | 2271.12 | 1805 / 1809 | 98% | 15.84 | 461 / 472 |
| prostate | 100% | 1558.77 | 244 / 245 | 97% | 9.24 | 485 / 502 |
| kidney | 100% | 1604.90 | 89 / 89 | 96% | 16.76 | 864 / 901 |
| adrenal gland | 100% | 1836.72 | 258 / 258 | 93% | 9.90 | 215 / 230 |
| uterus | 100% | 3025.68 | 170 / 170 | 93% | 9.66 | 428 / 459 |
| bladder | 100% | 2218.90 | 21 / 21 | 92% | 8.63 | 464 / 504 |
| pancreas | 83% | 639.48 | 271 / 328 | 98% | 10.34 | 174 / 178 |
| liver | 74% | 601.47 | 168 / 226 | 85% | 6.55 | 346 / 406 |
| adipose | 100% | 2310.63 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 36.38 | 29 / 29 |
| spleen | 100% | 2530.28 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1834.87 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 3125.74 | 915 / 929 | 0% | 0 | 0 / 0 |
| muscle | 97% | 1205.88 | 776 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 8.61 | 42 / 45 |
| heart | 91% | 1104.26 | 784 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 64% | 4.07 | 51 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006954 | Biological process | inflammatory response |
| GO_0050804 | Biological process | modulation of chemical synaptic transmission |
| GO_0006622 | Biological process | protein targeting to lysosome |
| GO_0032780 | Biological process | negative regulation of ATP-dependent activity |
| GO_0008333 | Biological process | endosome to lysosome transport |
| GO_0043271 | Biological process | negative regulation of monoatomic ion transport |
| GO_0006468 | Biological process | protein phosphorylation |
| GO_0045022 | Biological process | early endosome to late endosome transport |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0034451 | Cellular component | centriolar satellite |
| GO_0005769 | Cellular component | early endosome |
| GO_0032991 | Cellular component | protein-containing complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0005770 | Cellular component | late endosome |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0035091 | Molecular function | phosphatidylinositol binding |
| GO_0000166 | Molecular function | nucleotide binding |
| GO_0004672 | Molecular function | protein kinase activity |
| GO_0005524 | Molecular function | ATP binding |
| GO_0003779 | Molecular function | actin binding |
| Gene name | PXK |
| Protein name | PX domain-containing protein kinase-like protein (Modulator of Na,K-ATPase) (MONaKA) PXK PXK protein PX domain containing serine/threonine kinase like PX domain containing serine/threonine kinase like (PXK) |
| Synonyms | |
| Description | FUNCTION: Binds to and modulates brain Na,K-ATPase subunits ATP1B1 and ATP1B3 and may thereby participate in the regulation of electrical excitability and synaptic transmission. May not display kinase activity. . |
| Accessions | H7C4V0 ENST00000383716.7 [Q7Z7A4-2] H7BYG4 ENST00000484288.5 [Q7Z7A4-2] Q7Z7A4 C9IYJ2 U3KQS4 F8WDF7 Q32NE9 W5RWE6 F8WAW8 ENST00000302779.9 ENST00000479134.5 ENST00000468776.5 ENST00000383715.8 ENST00000495557.5 ENST00000356151.7 [Q7Z7A4-1] E9PD56 ENST00000463280.5 H7C529 W5RWD6 ENST00000491164.1 A0A0C4DG95 W5RX72 ENST00000477308.5 ENST00000459676.6 ENST00000479241.5 ENST00000493474.1 H7C4W2 |